Sign up to save your podcasts
Or
Share What to Expect from ASCO2021 and Hurray for Amgen!
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What to Expect from ASCO2021 and Hurray for Amgen!
This week on the podcast Agustin discusses the upcoming readouts from ASCO 2021, highlights the current situation for Covid manufacturers including the over-inflated CureVac ( $CVAC), and celebrates the recent milestone for drug development and the implications on other manufacturers within the KRAS space.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
View all episodes
By Biotech Bros LLC.This week on the podcast Agustin discusses the upcoming readouts from ASCO 2021, highlights the current situation for Covid manufacturers including the over-inflated CureVac ( $CVAC), and celebrates the recent milestone for drug development and the implications on other manufacturers within the KRAS space.
Make sure to like, comment, subscribe and follow me on Twitter @biotech_bros
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com